Start date: Sept. 6, 2021
Duration: 1 day
Registration start: July 29, 2021 Registration end date: Sept. 1, 2021 Registration late date: Sept. 1, 2021
Abstract start: July 29, 2021
Abstract end date: Sept. 1, 2021
Rare diseases are defined as conditions that affect fewer than 1:2,000 people; however, as a group of conditions they are quite common, affecting 1 in 17 individuals, which in the UK equates to 3.5 million people. Mutations in genes encoding the extracellular matrix components, cell-matrix adhesion complexes and signalling pathways are all implicated in rare disease. Moreover, rare diseases share common molecular mechanisms that can be targeted in order to find affordable treatments that can be applicable to common diseases and age-related conditions as well.
The meeting is hosted by Dr Katarzyna Pirog from the University of Newcastle.
Inês Alves (ANDO, Portugal)
Matt Warman (Harvard University, USA)
Brendan Lee (Baylor College of Medicine, USA)
Francesco Ramirez (Mount Sinai, USA)
Su Lwin (King’s College London, UK)
Alison Gartland (Sheffield University, UK)
Rachel Lennon (Manchester University, UK)
James Gallagher (University of Liverpool, UK)
The meeting is sponsored by The Company of Biologists
This meeting is no longer taking any registrations.
© 2021 British Society for Matrix Biology. All rights reserved.